Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/CDVA stock hub

CSE/CDVA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/CDVAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.8M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/CDVA

In the news

Latest news · CSE/CDVA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC16.7

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/CDVA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

CAD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 14.9M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA21864T1075
Last refreshed	2026-05-10
Market cap	CAD 9.8M
Price	CAD 0.05
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/CDVA
Website	https://www.cordovacann.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-27.62%
EV Earnings	-5.53x
EV/EBIT	44.95x
EV/EBITDA	16.05x
EV/FCF	17.39x
EV/Sales	1.06x
FCF yield	8.78%
P/B ratio	-1.79x
P/S ratio	0.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.36%
EBITDA Margin	4.27%
FCF margin	6.09%
Gross margin	27.7%
Gross Profit	CAD 3.9M
Gross Profit Growth	0.67%
Gross Profit Growth Q	-1.95%
Gross Profit Growth3 Y	4.83%
Gross Profit Growth5 Y	24.3%
Net Income	CAD -2.7M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-15.25%
Profit Margin	-19.16%
ROA	2.66
Roa5y	-6.74
ROCE	-11.74
ROIC	16.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-23.09%
Cagr3y	-34.13%
Cagr5y	-31.65%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	-45.24%
FCF Growth Q	-43.73%
OCF Growth	-42.8%
OCF Growth Q	-43.73%
Revenue Growth	-0.55x
Revenue Growth Q	-4.4x
Revenue Growth Years	5x
Revenue Growth3 Y	1.61x
Revenue Growth5 Y	25.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 1.8
Assets	CAD 6.5M
Cash	CAD 586,032
Current Assets	CAD 1.7M
Current Liabilities	CAD 9.3M
Debt	CAD 5.2M
Debt EBITDA	CAD 5.6
Debt FCF	CAD 6.07
Equity	CAD -5.5M
Interest Coverage	0.65
Liabilities	CAD 11.9M
Long Term Assets	CAD 4.8M
Long Term Liabilities	CAD 2.6M
Net Cash	CAD -4.6M
Net Cash By Market Cap	CAD -47.34
Net Debt EBITDA	CAD 7.69
Net Debt FCF	CAD 5.39
Tangible Book Value	CAD -9.1M
Tangible Book Value Per Share	CAD -0.08
WACC	5.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.18
Inventory Turnover	10.66
Net Working Capital	CAD -5.6M
Quick ratio	0.08
Working Capital	CAD -7.6M
Working Capital Turnover	CAD -1.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-23.08%
200-day SMA	0.11
3Y total return	-71.43%
50-day SMA	0.04
50-day SMA vs 200-day SMA	50under200
5Y total return	-85.07%
All Time High	2
All Time High Change	-97.5%
All Time High Date	2018-08-21
All Time Low	0.01
All Time Low Change	900%
All Time Low Date	2025-12-29
ATR	0.02
Beta	-0.11
Ch YTD	66.67
High	0.07
High52	0.15
High52 Date	2025-04-29
High52ch	-66.67%
Low	0.01
Low52	0.01
Low52 Date	2025-12-29
Low52ch	900%
Ma50ch	21.95%
Price vs 200-day SMA	-54.55%
RSI	53.49
RSI Monthly	44.94
RSI Weekly	43.69
Sharpe ratio	1.53x
Sortino ratio	4.55
Total Return	-0.15%
Tr YTD	66.67
Tr1m	100%
Tr1w	233.33%
Tr3m	42.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 331,944
Operating margin	2.36

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	98,649,848%
Net Borrowing	-2,145,598
Shares Insiders	6.09%
Shares Institutions	2.68%
Shares Qo Q	0%
Shares Yo Y	0.15%
Short Ratio	0.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 856,487
Average Volume	32,184.75x
Bv Per Share	-0.05
CAPEX	CAD -16,681
Ch1m	100
Ch1w	233.3
Ch1y	-23.08
Ch3m	42.86
Ch3y	-71.43
Ch5y	-85.07
Ch6m	100
Change	-37.5%
Change From Open	233.3
Close	0.08
Days Gap	-81.25
Depreciation Amortization	268,638
Dollar Volume	4,817
Earnings Date	2026-05-29
EBIT	CAD 331,944
EBITDA	CAD 600,582
EPS	CAD -0.02
F Score	5
FCF	CAD 856,487
FCF EV Yield	5.75x
Financing CF	-2,513,412
Fiscal Year End	June
Founded	1,997
Income Tax	CAD 314,090
Investing CF	1,548,933
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	0.08
Ma150ch	-34.47%
Ma20	0.03
Ma20ch	61.29%
Net CF	30,442
Next Earnings Date	2026-05-29
Open	0.02
P FCF Ratio	11.38
P OCF Ratio	11.17
Position In Range	66.67
Ppne	1,665,363
Price Date	2026-04-24
Price EBITDA	CAD 16.23
Relative Volume	2.99x
Revenue	14,054,216x
Tax By Revenue	2.23x
Tr6m	100%
Volume	96,340
Z Score	-8.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/CDVA pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/CDVA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/CDVA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.7%

Share of float held by funds and institutions

Insider ownership

+6.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CSE/CDVA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.5

Neutral momentum band

Price vs 200-day MA

-54.5%

50/200-day relationship not available

Beta (5Y)

-0.11

Less volatile than the market

Sharpe ratio

1.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/CDVA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/CDVA stock rating?

cse/CDVA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/CDVA analysis?

The full report lives at /stocks/cse/CDVA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/CDVA?

The latest report frames cse/CDVA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/CDVA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.